金銀花와 黃芩이 配伍된 處方劑의 抗炎症 效果 硏究

키워드

참고문헌 (39)

1. Shin MG, "Clinical herbalogy", Youngrimsa, pp.308~321 (1991)
2. Kang BS, "Clinical with herbal medicine", pp.287~290 (1994), Youngrimsa
3. Kim CM, "After translation TCM Dictionary", Jeongdam, pp.582~587 (1997)
4. State Pharmaceutical Administration, "Chinese herbal medicine", pp.1791~1817 (1998), Science and Technology Publisher
5. Tae BS, "Korean Dictionary of clinical medicine", pp.51~53 (1994), Euiseongdang
6. Kim HS, "Effects of flos lonicerae water extract on anti-rheumatiod arthritis", pp.2003
7. Jeong BS, "(Crude drug) illustrates Xiang drug dictionary", pp.864~865 (1990), Youngrimsa
8. Kim EJ, "Suppression by a sesquiterpene lactone from Carpesium divaricantum of inducible nitric oxide synthase by inhibiting nuclear factor-kB activation", Biochem Pharmarol, 61, pp.903~910 (2001)
9. Choi SM, "Screening of the Antibacterial Activity of Natural Products against Propionibacterium acnes", Archives of Pharmacal Research, 42, pp.89~94 (1998)
10. Shin YS, "Experimental study on the Yubaekpi anti-inflammatory and tissue regeneration", J Korean Med Ophthalmol Otolaryngol Dermatol, 14, pp.129~135 (2001)
11. Baek GH, "Antitumor Effects of the Ethyl Acetate Soluble Fraction of Lonicerae flos on Human Oral Epitheloid Carcinoma Cells", pp.1997
12. Tae J, "Anti-inflammatory effect of Lonicera japonica in proteinase-activated receptor 2-mediated paw edema", Clinica Chimica Acta, 330, pp.165~171 (2003)
13. Lee JH, "Anti-inflammatory effect of the aqueous extract from Lonicera japonica flower is related to inhibition of NF-kappaB activation through reducing I-kappaBalpha degradation in rat liver", Int J Mol Cell Med, 7, pp.79~83 (2001)
14. Ohta S, "Protective effects of Taiwan crude drugs on experimental liver injuries Yakugaku Zasshi.", 113, pp.870~880 (1993)
15. Jang SI, "Aqueous extract from Lonicera japonica flower Inhibits LPS-induced Inflammatory Mediators in RAW 264.7 Macrophages" (2005)
16. Hu S, "Influence of medicinal herbs on phagocytosis by bovine neutrophils", Zentralbl Veterinarmed A, 39, pp.593~599 (1992)
17. Tang W, "Chinese Drugs of plant origin", Springer-Verg, pp.919~929 (1992)
18. Abe K, "Biliary excretion of metabolites of baicalin and baicalein in rats", Chem Pharm Bull(Tokyo), 38(1), pp.209~211 (1990)
19. Li BQ, "The flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines", Immunopharmacology, 49(3), pp.295~306 (2000)
20. Krakauer T, "The flavonoid baicalin inhibits superantigeninduced inflammatory cytokines and chemokines", FEBS Lett, 500(1-2), pp.52~55 (2001)
21. Chen YC, "Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide", Biochem Pharmacol, 61(11), pp.1417~1427 (2001)
22. Ahmad N, "Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia", Journal of Leukocyte Biology, 71, pp.1005~1011 (2002)
23. Barnes PJ, "Nuclear factor-κB : a pivotal transcription factor in chronic inflammatory diseases", New England Journal Medecine, 336, pp.1066~1071 (1997)
24. Coker PK, "Pulmonary fibrosis : cytokines in the balance", European Respiratory Journal, 11, pp.1218~1221 (1998)
25. De Nardin E, "The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease", Annals of Periodontology, 6, pp.3040~ (2001)
26. Dinarello CA, "Cytokines as endogenous pyrogens", Journal of Infectious Diseases, 179, pp.294~304 (1999)
27. Feldmann M, "Role of cytokines in rheumatoid arthritis", Annual Review ofImmunology, 14, pp.397~440 (1996)
28. Isomaki P, "Pro-and anti-inflammatory cytokines in rheumatoid arthritis", Annals of Medicine, 29, pp.499~507 (1997)
29. Kotake Y, "Inhibition of NF-kappaB, iNOS mRNA, COX2mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone(PBN)", Biochimica Etbiophysica Acta, 1448, pp.77~84 (1998)
30. Kroncke KD, "Nitric oxide: cytotoxicity versus cytoprotectionhow, why, when, and where?", Nitric Oxide, 1, pp.107~120 (1997)
31. Birkenkamp KU, "The p38MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway", Br J Pharmacol, 131, pp.99~107 (2001)
32. Bian ZM, "Human RPE-monocyte co-culture induces chemokine gene expression through activation of MAPK and NIK cascade", Exp Eye Res, 76, pp.573~583 (2003)
33. Lee HW, "Phorbol 12-myristate 13-acetate up-regulates the transcription of MUC2 intestinal mucin via Ras ERK and NF-kappaB", J Biol Chem, 277, pp.32624~32631 (2002)
34. Majumdar S, "Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation", J Immunol, 167, pp.2911~2920 (2001)
35. Garrington TP, "Organization and regulation of mitogen-activated protein kinase signaling pathways", Curr Opin Cell Biol, 11, pp.211~218 (1999)
36. Mancuso G, "Mitogen-activated protein kinases and NF-kB are involved in TNF-α responses to group B streptococci", J Immunol, 169, pp.1401~1409 (2002)
37. Sha WC, "Targeted disruption of the p50 subunit of NF-kB leads to multifocal defects in immune responses", Cell, 80, pp.321~330 (1995)
38. Verma Q, "Nat Rev", Immunol, 2, pp.725~734 (2002)
39. Jang SI, "Hepatoprotective effect of baicalin, a major flavone from Scutellaria radix, on acetaminophen-induced liver injury in mice", Immunopharmacol Immunotoxicol, 25(4), pp.585~594 (2003)

관련 논문AI추천